Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.785 EUR
−86.73 M EUR
0.00 EUR
27.28 M
About Mind Medicine (MindMed) Inc.
Sector
CEO
Robert Barrow
Headquarters
New York
Website
Founded
2010
FIGI
BBG00FD7MXV5
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MIND MEDICINE (MINDMED) stocks are traded under the ticker MMQ.
We've gathered analysts' opinions on MIND MEDICINE (MINDMED) future price: according to them, MMQ price has a max estimate of 51.63 EUR and a min estimate of 15.02 EUR. Watch MMQ chart and read a more detailed MIND MEDICINE (MINDMED) stock forecast: see what analysts think of MIND MEDICINE (MINDMED) and suggest that you do with its stocks.
Yes, you can track MIND MEDICINE (MINDMED) financials in yearly and quarterly reports right on TradingView.
MIND MEDICINE (MINDMED) is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
MMQ earnings for the last quarter are −0.16 EUR per share, whereas the estimation was −0.25 EUR resulting in a 35.02% surprise. The estimated earnings for the next quarter are −0.29 EUR per share. See more details about MIND MEDICINE (MINDMED) earnings.
MIND MEDICINE (MINDMED) revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MMQ net income for the last quarter is −12.29 M EUR, while the quarter before that showed −5.47 M EUR of net income which accounts for −124.88% change. Track more MIND MEDICINE (MINDMED) financial stats to get the full picture.
No, MMQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 14, 2024, the company has 57.00 employees. See our rating of the largest employees — is MIND MEDICINE (MINDMED) on this list?
Like other stocks, MMQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MIND MEDICINE (MINDMED) stock right from TradingView charts — choose your broker and connect to your account.